Targeting Mitochondrial Dysfunction in Microglia: A New Frontier for Treating Neurodegenerative Diseases

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Neurodegenerative diseases like Alzheimer's (AD), Parkinson's (PD), and ALS are significant health concerns.
• Microglia-driven neuroinflammation and mitochondrial dysfunction are key factors in disease initiation and progression.

Purpose of the Study:

• To review how mitochondrial alterations regulate microglial activation in AD, PD, and ALS.
• To identify conserved and disease-specific mechanisms linking mitochondrial health to neuroinflammation.

Main Methods:

• Comprehensive literature review of studies on microglial mitochondria in neurodegenerative diseases.
• Analysis of conserved pathways such as metabolic reprogramming and mitophagy.
• Examination of disease-specific molecular triggers like Aβ, α-synuclein, and TDP-43.

Main Results:

• Conserved mechanisms including metabolic reprogramming, impaired mitophagy, and inflammatory signaling are regulated by mitochondrial alterations.
• Disease-specific molecules engage these pathways differently across AD, PD, and ALS.
• Current therapeutic strategies targeting microglial mitochondria are mostly preclinical, with some emerging targets needing validation.

Conclusions:

• Preserving microglial mitochondrial health is a promising therapeutic strategy for neurodegenerative diseases.
• Further research and validation are needed to translate preclinical findings into clinical applications.
• Targeting microglial mitochondrial pathways offers a novel frontier for treating AD, PD, and ALS.